Nih
Nih funding pages collect matching grants, scholarships, benefits, fellowships, and other programs from the FindMyMoney.App directory. Use this page to compare current opportunities, then verify deadlines and eligibility on the official source before applying.
PAR-25-234: NINDS Ruth L. Kirschstein NRSA Postdoctoral Fellowship (F32, Clinical Trial Not Allowed)
A closed NINDS F32 postdoctoral fellowship opportunity that supported mentored research training in neuroscience and related areas. NIH ended PAR-25-234 early; the final receipt date was 2026-06-09 and no replacement cycle is announced in the official notice reviewed.
PAR-25-270: NCCIH Natural Product Early Phase Clinical Trial Award (R33)
NIH NOFO for R33 early-phase natural-product clinical trials focused on target-engagement evidence before larger efficacy studies, with a direct-cost cap of $1,050,000 over up to 3 years and strict clinical-trial-only eligibility.
PAR-25-322: Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)
NIH’s ESI-focused R01 NOFO for projects in a new research direction without preliminary data; the next new-application receipt date is 2026-09-28, with recurring dates through 2028 and up to a 5-year project period.
PAR-25-337: Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01, Clinical Trial Optional)
NIH funding opportunity for translational R01 projects that pair academic and industrial partners to move diagnostics, imaging, and care-delivery technologies toward real end-user use in pre-clinical, clinical, and non-clinical settings, with application budgets limited to $499,000 in direct costs per year for up to 5 years.
PAR-25-415: Support for Research Excellence (SuRE-First) Award (R16)
NIH NIGMS SuRE-First grants provide competitive direct research funding to first-time independent faculty at resource-limited U.S. institutions to build research capacity and involve students in biomedical research.
PAR-25-449: Mind and Body Interventions to Restore Whole Person Health via Emotional Well-Being Mechanisms (R61/R33 Clinical Trial Required)
A NCCIH phased NIH parent R61/R33 NOFO supporting mind-body mechanistic clinical trials with strong preliminary data, explicit feasibility milestones, and continuation criteria, with recurring submission cycles into the 2027 review cycle.
PAR-26-001: Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for Alcohol, Tobacco, and Other Drugs (ATOD) Use and Misuse in Adult Populations that Experience Health Disparities
A recurring NIH parent announcement for NIH-defined clinical trial R01 projects that test and scale SBIRT/P interventions for ATOD use and misuse among adults affected by health disparities.
PAR-26-042: Research Grants in Clinical Informatics (R01 Clinical Trial Optional)
NIH’s National Library of Medicine (NLM) supports R01 research grants to develop and evaluate scalable, reusable clinical informatics methods and tools, with a direct-cost cap of $250,000 per year.
PAR-27-013: Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (U24)
The NHLBI PAR-27-013 funding opportunity supports Data Coordinating Center (DCC) teams that coordinate multi-site investigator-initiated clinical trials in a milestone-driven cooperative agreement, submitted alongside a companion Clinical Coordinating Center application. The next listed application due date is October 2, 2026.
PAR-27-015: Community-Based Participatory Research to Advance Data and Practice Transformation (ADAPT) for Optimizing Oral Health for All
A NIH phased cooperative agreement (UG3/UH3) to fund community-partnered interventions that improve oral health through cross-sector data and practice transformation in US communities.